U-Chart Analysis:MIZUHO MEDY CO.,LTD.:4595

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index MIZUHO MEDY CO.,LTD. Go to web site 4595 Medicals 東証スタンダード December 1, 2000 2015.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

MIZUHO MEDY CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

MIZUHO MEDY CO.,LTD. Balance Sheet 2024年12月期 MIZUHO MEDY CO.,LTD. Balance Sheet 2023年12月期 MIZUHO MEDY CO.,LTD. Balance Sheet 2022年12月期 MIZUHO MEDY CO.,LTD. Balance Sheet 2021年12月期 MIZUHO MEDY CO.,LTD. Balance Sheet 2020年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents 11,246 10,135 8,702 4,327 54
Other Current AssetsHelp 6,752 6,155 7,798 5,334 3,592
Tangible Fixed AssetsHelp 2,271 2,251 2,153 2,099 2,128
Intangible Fixed AssetHelp 10 12 14 12 12
Investments and OthersHelp 450 395 434 421 266
Total AssetsHelp 20,729 18,948 19,102 12,193 6,052
Total Current LiabilitiesHelp 3,376 3,272 4,819 4,164 1,895
Total Long-term LiabilitiesHelp - 0 0 0 373
Shareholder's EquityHelp 17,353 15,676 14,283 8,029 3,784
Total LiabilitiesHelp 20,729 18,948 19,102 12,193 6,052

MIZUHO MEDY CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

MIZUHO MEDY CO.,LTD. Profit and Loss Account 2024年12月期 MIZUHO MEDY CO.,LTD. Profit and Loss Account 2023年12月期 MIZUHO MEDY CO.,LTD. Profit and Loss Account 2022年12月期 MIZUHO MEDY CO.,LTD. Profit and Loss Account 2021年12月期 MIZUHO MEDY CO.,LTD. Profit and Loss Account 2020年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales 11,429 10,990 17,582 13,137 4,205
Total Sales 11,429 10,990 17,582 13,137 4,205
Cost of SalesHelp 3,345 2,916 3,482 3,234 1,445
Other Costs and RevenueHelp 4,310 4,300 6,262 5,086 2,455
Total CostsHelp 7,655 7,215 9,744 8,321 3,899
Net RevenueHelp 8,084 8,074 14,100 9,903 2,761
Earnings Before TaxHelp 5,167 5,292 11,071 6,825 415
Net IncomeHelp 3,774 3,774 7,838 4,817 306
Net Income 3,774 3,774 7,838 4,817 306

MIZUHO MEDY CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

MIZUHO MEDY CO.,LTD. Cash Flow Statement 2024年12月期 MIZUHO MEDY CO.,LTD. Cash Flow Statement 2023年12月期 MIZUHO MEDY CO.,LTD. Cash Flow Statement 2022年12月期 MIZUHO MEDY CO.,LTD. Cash Flow Statement 2021年12月期 MIZUHO MEDY CO.,LTD. Cash Flow Statement 2020年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help 3,348 3,992 6,173 5,597 295
Investing Cash Flow(ICF)Help -307 -270 -1,554 -160 -97
Financing Cash FlowHelp -2,094 -2,381 -1,571 -1,165 -361
Exchange Difference of Cash and Cash EquivalentsHelp 1 1 0 0 0
Net Increase and Decrease in Cash and Cash Equivalentsn 948 1,341 3,049 4,272 -163

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

MIZUHO MEDY CO.,LTD.
Chiyoda Corporation
MORINAGA MILK INDUSTRY CO.,LTD.
KEL CORPORATION
HI-LEX CORPORATION

Company where related level is highHelp

Kyowa Kirin Co.,Ltd.
OncoTherapy Science,Inc.
MIKASA SEIYAKU CO.,LTD.
BrightPath Biotherapeutics Co., Ltd.
Cyfuse Biomedical K.K.
MORISHITA JINTAN CO.,LTD.
Takeda Pharmaceutical Company Limited
Noile-Immune Biotech Inc.
R-TECH UENO,LTD.
Renascience Inc.